MedTrace Logo

Treatment of Vascular Lesions With a Tandem 532/1064 nm Laser

NCT00585338 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 1

Last updated 2022-10-20

No results posted yet for this study

Summary

Dermatologists have for many years treated vascular lesions by a variety of modalities including cryosurgery, electrotherapy, dermabrasion and radiation.

It has been hypothesized that simultaneous delivery of these two wavelengths may provide safer, and in some cases more effective, vascular lesion removal.

The Tandem laser is capable of emitting multiple cryogen spurts intermittently with multiple 532/1064 nm laser pulses.This mode may reduce malformed blood vessels with a low incidence of long-term side effects.

Conditions

  • Vascular Lesion

Interventions

DEVICE

Tandem 532/1064 nm Laser

Treatment of Vascular Lesions With a Tandem 532/1064 nm Laser

Sponsors & Collaborators

  • Beckman Laser Institute University of California Irvine

    collaborator OTHER

  • University of California, Irvine

    lead OTHER

Principal Investigators

  • John S Nelson, M.D, PhD · Beckman Laser Institute University of California Irvine

  • Wangcun Jia, PhD · Beckman Laser Institute University of California Irvine

  • Kristen Kelly, M.D · Beckman Laser Institute University of California Irvine

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-12-31
Primary Completion
2010-10-31
Completion
2010-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00585338 on ClinicalTrials.gov